HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
LeadSI
Supernova Invest
Activity from announced rounds
Activity in this selectionOct 18, 2026 · Jul 21, 2026
Supernova Invest is the French deep-technology manager whose own materials identify Quobly and HighLife.
Recorded funding activity
HighLife develops a transcatheter heart-valve system. Exein secures devices, while Moa discovers herbicides. Named seed funds remain separate from the manager-level history.
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 1 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $391.3M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionExein
Embedded cybersecurity software for device manufacturers that protects connected products from firmware vulnerabilities and malicious activity at runtime.
$270MUndisclosed
ParticipantMoa Technology
An agricultural biotechnology company focused on discovering novel mode of action herbicides
£22.2MSeries C
Role not disclosed